Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Short-term Activity Ratios (Summary)
Turnover Ratios
Average No. Days
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
The analysis of operational activity ratios from 2019 to 2023 reveals a significant shift in the company's working capital efficiency, primarily driven by substantial changes in inventory management and a subsequent extension of the cash conversion cycle.
- Inventory Management
- A marked decrease in inventory turnover occurred after 2019, falling from 1.42 to a low of 0.70 in 2020, before stabilizing between 0.87 and 0.96 in subsequent years. This trend is mirrored in the average inventory processing period, which expanded from 257 days in 2019 to a peak of 519 days in 2020, remaining above 400 days through 2023. This indicates a slower movement of goods and a higher volume of capital tied up in inventory.
- Receivables Performance
- The receivables turnover remained relatively stable throughout the period, with a slight upward trend peaking at 6.86 in 2022. Consequently, the average receivable collection period demonstrated a gradual improvement, decreasing from 63 days in 2019 and 2020 to 57 days by 2023. This suggests a consistent and efficient process for converting credit sales into cash.
- Payables Dynamics
- The payables turnover experienced a sharp spike in 2020, rising to 14.32 from 6.15 in 2019, which corresponded with a drastic reduction in the average payables payment period from 59 days to 25 days. While the payment period lengthened slightly in the following years, reaching 34 days in 2023, it remained considerably shorter than the 2019 baseline, indicating a more accelerated payment schedule to suppliers.
- Operational and Cash Conversion Cycles
- The operating cycle expanded significantly from 320 days in 2019 to a peak of 582 days in 2020, before settling at 469 days by 2023. Because the payables payment period remained shorter than in 2019, the cash conversion cycle (CCC) saw an even more pronounced extension, rising from 261 days in 2019 to 435 days in 2023. The CCC is heavily influenced by the prolonged inventory processing period, suggesting that the company requires significantly more time to recover cash investments in operations than it did in 2019.
Working capital turnover showed significant volatility, increasing from 0.22 in 2019 to a peak of 1.24 in 2022, before declining to 0.65 in 2023. The overall trend indicates that while receivables collection is efficient, the operational efficiency is constrained by slow inventory turnover, resulting in a prolonged cash conversion cycle that persists at levels substantially higher than the 2019 starting point.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Inventory Turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Cost of revenue | 95,388) | 64,996) | 41,438) | 20,991) | 17,159) | |
| Inventory | 107,587) | 75,112) | 42,978) | 29,859) | 12,074) | |
| Short-term Activity Ratio | ||||||
| Inventory turnover1 | 0.89 | 0.87 | 0.96 | 0.70 | 1.42 | |
| Benchmarks | ||||||
| Inventory Turnover, Competitors2 | ||||||
| Abbott Laboratories | 2.74 | 3.10 | 3.59 | — | — | |
| Intuitive Surgical Inc. | 1.96 | 2.27 | 2.98 | — | — | |
| Medtronic PLC | 2.03 | 2.20 | 2.43 | — | — | |
| Inventory Turnover, Sector | ||||||
| Health Care Equipment & Services | 30.37 | 30.70 | 31.85 | — | — | |
| Inventory Turnover, Industry | ||||||
| Health Care | 7.36 | 7.85 | 7.90 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Inventory turnover = Cost of revenue ÷ Inventory
= 95,388 ÷ 107,587 = 0.89
2 Click competitor name to see calculations.
A significant expansion in both cost of revenue and inventory levels is observed between 2019 and 2023. Cost of revenue grew from 17,159 thousand US$ to 95,388 thousand US$, while inventory increased from 12,074 thousand US$ to 107,587 thousand US$. This indicates a period of rapid scaling in operational volume.
- Inventory Turnover Volatility
- A sharp decline in the inventory turnover ratio occurred between 2019 and 2020, falling from 1.42 to 0.70. This represents a substantial reduction in the efficiency of inventory utilization during that fiscal transition.
- Ratio Stabilization
- Following the initial decline, the turnover ratio entered a period of relative stability from 2021 through 2023, fluctuating between 0.87 and 0.96. The ratio has failed to recover to the 2019 level of 1.42, suggesting a structural shift in how inventory is managed or held.
- Inventory Growth Relative to Revenue Costs
- Inventory levels have increased at a pace that generally exceeds the growth of the cost of revenue. By the end of 2023, the total value of inventory surpassed the annual cost of revenue, resulting in a turnover ratio that remains below 1.0.
The overall trend indicates that while the scale of operations has increased substantially, the velocity of inventory turnover has decreased and plateaued. This pattern suggests a strategy of maintaining higher safety stocks or an anticipation of future demand that outweighs current cost of revenue expenditures.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Receivables Turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Revenue | 730,230) | 489,733) | 237,146) | 67,789) | 42,927) | |
| Accounts receivable, net | 114,552) | 71,366) | 37,435) | 11,689) | 7,377) | |
| Short-term Activity Ratio | ||||||
| Receivables turnover1 | 6.37 | 6.86 | 6.33 | 5.80 | 5.82 | |
| Benchmarks | ||||||
| Receivables Turnover, Competitors2 | ||||||
| Abbott Laboratories | 6.11 | 7.02 | 6.64 | — | — | |
| Elevance Health Inc. | 18.08 | 18.81 | 20.66 | — | — | |
| Intuitive Surgical Inc. | 6.30 | 6.60 | 7.30 | — | — | |
| Medtronic PLC | 5.21 | 5.71 | 5.51 | — | — | |
| UnitedHealth Group Inc. | 17.27 | 18.22 | 20.07 | — | — | |
| Receivables Turnover, Sector | ||||||
| Health Care Equipment & Services | 13.74 | 14.33 | 14.76 | — | — | |
| Receivables Turnover, Industry | ||||||
| Health Care | 7.66 | 8.22 | 8.00 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Receivables turnover = Revenue ÷ Accounts receivable, net
= 730,230 ÷ 114,552 = 6.37
2 Click competitor name to see calculations.
The analysis of receivables management between 2019 and 2023 reveals a period of rapid operational expansion coupled with stable collection efficiency. While revenue experienced exponential growth, the receivables turnover ratio remained within a narrow range, indicating that consistent credit control processes were maintained during a phase of significant scaling.
- Revenue and Accounts Receivable Growth
- Revenue increased from US$ 42.9 million in 2019 to US$ 730.2 million in 2023. In parallel, net accounts receivable rose from US$ 7.4 million to US$ 114.6 million. The proportional increase in both metrics suggests that the growth in receivables is primarily a direct result of the substantial increase in sales volume rather than a systemic deterioration in credit terms or collection effectiveness.
- Receivables Turnover Trends
- The receivables turnover ratio exhibited marginal fluctuations, starting at 5.82 in 2019 and ending at 6.37 in 2023. An increase in efficiency was observed between 2020 and 2022, with the ratio peaking at 6.86, suggesting an accelerated collection cycle or more stringent credit policies during that window. A slight moderation to 6.37 occurred in 2023, indicating that receivables grew at a slightly faster pace than revenue in the final year of the period.
- Operational Efficiency Insights
- The stability of the turnover ratio—maintaining a range between 5.80 and 6.86—demonstrates a scalable approach to accounts receivable management. The ability to sustain this level of efficiency while revenue grew by approximately 1,600% suggests a robust operational framework capable of handling increased transaction volumes without compromising the velocity of cash inflows from customers.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Payables Turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Cost of revenue | 95,388) | 64,996) | 41,438) | 20,991) | 17,159) | |
| Accounts payable | 8,868) | 6,721) | 3,520) | 1,466) | 2,790) | |
| Short-term Activity Ratio | ||||||
| Payables turnover1 | 10.76 | 9.67 | 11.77 | 14.32 | 6.15 | |
| Benchmarks | ||||||
| Payables Turnover, Competitors2 | ||||||
| Abbott Laboratories | 4.19 | 4.15 | 4.21 | — | — | |
| Elevance Health Inc. | 7.72 | 7.47 | 7.59 | — | — | |
| Intuitive Surgical Inc. | 12.69 | 13.78 | 14.45 | — | — | |
| Medtronic PLC | 4.03 | 4.46 | 4.98 | — | — | |
| UnitedHealth Group Inc. | 7.47 | 7.26 | 7.63 | — | — | |
| Payables Turnover, Sector | ||||||
| Health Care Equipment & Services | 7.14 | 6.94 | 7.18 | — | — | |
| Payables Turnover, Industry | ||||||
| Health Care | 5.97 | 5.79 | 5.84 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Payables turnover = Cost of revenue ÷ Accounts payable
= 95,388 ÷ 8,868 = 10.76
2 Click competitor name to see calculations.
The financial trajectory from 2019 to 2023 is characterized by aggressive operational scaling, evidenced by a substantial and consistent increase in the cost of revenue. While accounts payable have grown to support this expansion, the efficiency of the payables cycle has experienced notable volatility.
- Cost of Revenue Trends
- A sustained upward trend is observed in the cost of revenue, which increased from 17.16 million USD in 2019 to 95.39 million USD by the end of 2023. The most significant accelerations occurred between 2020 and 2022, signaling a period of rapid growth in production or service delivery requirements.
- Accounts Payable Dynamics
- Accounts payable exhibited a non-linear progression, marked by a sharp decrease in 2020 to 1.47 million USD followed by a steady recovery and expansion. By 2023, the balance reached 8.87 million USD, reflecting an increased reliance on supplier credit to finance growing operational costs.
- Payables Turnover Ratio Analysis
- The payables turnover ratio peaked in 2020 at 14.32, indicating a rapid settlement of obligations relative to the cost of revenue during that period. Subsequently, the ratio entered a period of moderate decline, reaching a low of 9.67 in 2022, before correcting slightly to 10.76 in 2023. This movement suggests a stabilization of supplier payment terms as operations scaled, transitioning away from the higher volatility observed in the 2019-2020 window.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Working Capital Turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Current assets | 1,225,260) | 459,263) | 285,902) | 246,300) | 216,697) | |
| Less: Current liabilities | 104,205) | 63,374) | 51,628) | 25,581) | 24,008) | |
| Working capital | 1,121,055) | 395,889) | 234,274) | 220,719) | 192,689) | |
| Revenue | 730,230) | 489,733) | 237,146) | 67,789) | 42,927) | |
| Short-term Activity Ratio | ||||||
| Working capital turnover1 | 0.65 | 1.24 | 1.01 | 0.31 | 0.22 | |
| Benchmarks | ||||||
| Working Capital Turnover, Competitors2 | ||||||
| Abbott Laboratories | 4.54 | 4.48 | 3.87 | — | — | |
| Elevance Health Inc. | 7.83 | 8.37 | 7.23 | — | — | |
| Intuitive Surgical Inc. | 1.14 | 1.29 | 1.22 | — | — | |
| Medtronic PLC | 2.47 | 2.97 | 2.15 | — | — | |
| UnitedHealth Group Inc. | — | — | — | — | — | |
| Working Capital Turnover, Sector | ||||||
| Health Care Equipment & Services | 23.27 | 25.59 | 16.28 | — | — | |
| Working Capital Turnover, Industry | ||||||
| Health Care | 10.99 | 11.30 | 8.57 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Working capital turnover = Revenue ÷ Working capital
= 730,230 ÷ 1,121,055 = 0.65
2 Click competitor name to see calculations.
Between 2019 and 2023, a period of substantial expansion is evident in both revenue and working capital. Revenue grew from 42.9 million US$ to 730.2 million US$, reflecting strong top-line growth. Concurrently, working capital increased from 192.7 million US$ to 1.12 billion US$, with the most significant escalation occurring in the final fiscal year.
- Working Capital Turnover Trend (2019-2022)
- An improving trend in asset utilization was observed from 2019 to 2022, as the turnover ratio rose steadily from 0.22 to 1.24. This progression indicates that the organization became increasingly efficient at generating revenue relative to its investment in working capital during this four-year period.
- Working Capital Turnover Divergence (2023)
- In 2023, the turnover ratio experienced a significant contraction, falling to 0.65. While revenue continued to grow, the expansion of working capital outpaced revenue growth considerably. This suggests a disproportionate increase in current assets relative to current liabilities, which resulted in a decline in the efficiency of short-term operating assets.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Average Inventory Processing Period
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Inventory turnover | 0.89 | 0.87 | 0.96 | 0.70 | 1.42 | |
| Short-term Activity Ratio (no. days) | ||||||
| Average inventory processing period1 | 412 | 422 | 379 | 519 | 257 | |
| Benchmarks (no. days) | ||||||
| Average Inventory Processing Period, Competitors2 | ||||||
| Abbott Laboratories | 133 | 118 | 102 | — | — | |
| Intuitive Surgical Inc. | 186 | 161 | 122 | — | — | |
| Medtronic PLC | 180 | 166 | 150 | — | — | |
| Average Inventory Processing Period, Sector | ||||||
| Health Care Equipment & Services | 12 | 12 | 11 | — | — | |
| Average Inventory Processing Period, Industry | ||||||
| Health Care | 50 | 46 | 46 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 0.89 = 412
2 Click competitor name to see calculations.
The inventory management efficiency of the organization experienced a significant shift between 2019 and 2023, characterized by a sharp decline in turnover followed by a period of volatility and eventual stabilization at a lower efficiency level than the initial baseline.
- Inventory Turnover
- A marked reduction in the turnover ratio occurred between 2019 and 2020, falling from 1.42 to 0.70. Although a recovery was observed in 2021 with an increase to 0.96, the ratio subsequently stabilized, ending 2023 at 0.89. This indicates that the velocity of inventory movement has remained consistently lower than the 2019 levels.
- Average Inventory Processing Period
- The processing period mirrored the turnover trend, expanding from 257 days in 2019 to a peak of 519 days in 2020. Despite a contraction to 379 days in 2021, the period increased again to 422 days in 2022 and concluded 2023 at 412 days. The sustained increase in the number of days required to process inventory suggests a prolonged operational cycle compared to the 2019 baseline.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Average Receivable Collection Period
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Receivables turnover | 6.37 | 6.86 | 6.33 | 5.80 | 5.82 | |
| Short-term Activity Ratio (no. days) | ||||||
| Average receivable collection period1 | 57 | 53 | 58 | 63 | 63 | |
| Benchmarks (no. days) | ||||||
| Average Receivable Collection Period, Competitors2 | ||||||
| Abbott Laboratories | 60 | 52 | 55 | — | — | |
| Elevance Health Inc. | 20 | 19 | 18 | — | — | |
| Intuitive Surgical Inc. | 58 | 55 | 50 | — | — | |
| Medtronic PLC | 70 | 64 | 66 | — | — | |
| UnitedHealth Group Inc. | 21 | 20 | 18 | — | — | |
| Average Receivable Collection Period, Sector | ||||||
| Health Care Equipment & Services | 27 | 25 | 25 | — | — | |
| Average Receivable Collection Period, Industry | ||||||
| Health Care | 48 | 44 | 46 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 6.37 = 57
2 Click competitor name to see calculations.
Analysis of the receivables activity reveals a period of efficiency gains between 2020 and 2022, followed by a slight normalization in 2023. The relationship between turnover and collection time remains consistent, reflecting a direct correlation between the speed of credit recovery and the turnover ratio.
- Receivables Turnover
- The turnover ratio remained relatively stable between 2019 and 2020, holding at 5.82 and 5.80, respectively. An upward trend emerged starting in 2021, with the ratio peaking at 6.86 in 2022, which indicates an increase in the frequency with which the company converted its receivables into cash. A moderate decline to 6.37 occurred in 2023, although the figure remains elevated compared to the 2019-2020 period.
- Average Receivable Collection Period
- The collection period held steady at 63 days from 2019 through 2020. A progressive improvement in collection efficiency was observed from 2021 to 2022, with the period decreasing to 58 days and then reaching a minimum of 53 days. In 2023, the collection period experienced a slight increase to 57 days. Despite this minor uptick, the overall trend over the five-year period indicates a net reduction in the time required to collect outstanding receivables.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Operating Cycle
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Average inventory processing period | 412 | 422 | 379 | 519 | 257 | |
| Average receivable collection period | 57 | 53 | 58 | 63 | 63 | |
| Short-term Activity Ratio | ||||||
| Operating cycle1 | 469 | 475 | 437 | 582 | 320 | |
| Benchmarks | ||||||
| Operating Cycle, Competitors2 | ||||||
| Abbott Laboratories | 193 | 170 | 157 | — | — | |
| Intuitive Surgical Inc. | 244 | 216 | 172 | — | — | |
| Medtronic PLC | 250 | 230 | 216 | — | — | |
| Operating Cycle, Sector | ||||||
| Health Care Equipment & Services | 39 | 37 | 36 | — | — | |
| Operating Cycle, Industry | ||||||
| Health Care | 98 | 90 | 92 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 412 + 57 = 469
2 Click competitor name to see calculations.
The operating cycle experienced significant volatility between 2019 and 2023, characterized by a substantial expansion in 2020 followed by a period of partial correction and relative stabilization. The overall duration of the cycle remains elevated compared to the 2019 baseline, driven primarily by fluctuations in inventory management.
- Average Inventory Processing Period
- A marked increase in the inventory processing period is observed, rising from 257 days in 2019 to a peak of 519 days in 2020. Although a reduction to 379 days occurred in 2021, the period trended upward again to 422 days in 2022 before settling at 412 days in 2023. This indicates a significant extension in the time required to convert inventory into sales over the analyzed period.
- Average Receivable Collection Period
- The receivable collection period demonstrated relative stability and a general trend toward improvement. Holding steady at 63 days through 2020, the period declined consistently to 53 days by 2022. A slight increase to 57 days was noted in 2023, but the overall trend suggests a maintained efficiency in converting receivables into cash.
- Operating Cycle Synthesis
- The total operating cycle closely mirrors the movements of the inventory processing period due to the comparative stability of the collection period. The cycle expanded from 320 days in 2019 to 582 days in 2020, subsequently fluctuating between 437 and 475 days from 2021 through 2023. The data indicates that the primary driver of operating cycle inefficiency is the prolonged inventory hold time rather than delays in payment collection.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Average Payables Payment Period
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Payables turnover | 10.76 | 9.67 | 11.77 | 14.32 | 6.15 | |
| Short-term Activity Ratio (no. days) | ||||||
| Average payables payment period1 | 34 | 38 | 31 | 25 | 59 | |
| Benchmarks (no. days) | ||||||
| Average Payables Payment Period, Competitors2 | ||||||
| Abbott Laboratories | 87 | 88 | 87 | — | — | |
| Elevance Health Inc. | 47 | 49 | 48 | — | — | |
| Intuitive Surgical Inc. | 29 | 26 | 25 | — | — | |
| Medtronic PLC | 91 | 82 | 73 | — | — | |
| UnitedHealth Group Inc. | 49 | 50 | 48 | — | — | |
| Average Payables Payment Period, Sector | ||||||
| Health Care Equipment & Services | 51 | 53 | 51 | — | — | |
| Average Payables Payment Period, Industry | ||||||
| Health Care | 61 | 63 | 63 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 10.76 = 34
2 Click competitor name to see calculations.
The analysis of short-term operating activity reveals significant volatility in accounts payable management between 2019 and 2023, characterized by an initial sharp contraction in the payment cycle followed by a period of gradual extension and eventual stabilization.
- Payables Turnover
- A substantial increase in the payables turnover ratio occurred between 2019 and 2020, rising from 6.15 to a peak of 14.32. This movement was followed by a consistent downward trend through 2022, where the ratio reached 9.67, before exhibiting a slight recovery to 10.76 by the end of 2023. The fluctuations suggest a period of aggressive settlement of obligations followed by a transition toward a more moderated turnover rate.
- Average Payables Payment Period
- The average duration to settle payables experienced a sharp decline from 59 days in 2019 to 25 days in 2020. Subsequently, a gradual upward trend was observed, with the payment period increasing to 31 days in 2021 and peaking at 38 days in 2022. A modest reduction to 34 days was recorded in 2023. The transition from a nearly 60-day cycle to a stabilized range between 25 and 38 days indicates a fundamental shift in the timing of cash outflows related to supplier obligations, reflecting a more accelerated payment cadence compared to 2019 levels.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Cash Conversion Cycle
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Average inventory processing period | 412 | 422 | 379 | 519 | 257 | |
| Average receivable collection period | 57 | 53 | 58 | 63 | 63 | |
| Average payables payment period | 34 | 38 | 31 | 25 | 59 | |
| Short-term Activity Ratio | ||||||
| Cash conversion cycle1 | 435 | 437 | 406 | 557 | 261 | |
| Benchmarks | ||||||
| Cash Conversion Cycle, Competitors2 | ||||||
| Abbott Laboratories | 106 | 82 | 70 | — | — | |
| Intuitive Surgical Inc. | 215 | 190 | 147 | — | — | |
| Medtronic PLC | 159 | 148 | 143 | — | — | |
| Cash Conversion Cycle, Sector | ||||||
| Health Care Equipment & Services | -12 | -16 | -15 | — | — | |
| Cash Conversion Cycle, Industry | ||||||
| Health Care | 37 | 27 | 29 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 412 + 57 – 34 = 435
2 Click competitor name to see calculations.
The cash conversion cycle exhibits significant volatility over the analyzed five-year period, characterized by a substantial spike in 2020 followed by a period of relative stabilization at an elevated level. The overall cycle expanded from 261 days in 2019 to a peak of 557 days in 2020, before settling between 406 and 437 days from 2021 through 2023. This indicates a prolonged duration required to convert resource inputs into cash flows from sales.
- Average Inventory Processing Period
- Inventory management is the primary driver of the cash conversion cycle's fluctuations. A sharp increase is observed in 2020, where the period more than doubled to 519 days. While this figure declined to 379 days in 2021, it remained high, fluctuating between 412 and 422 days in 2022 and 2023. The sustained high number of days suggests a significant investment in inventory and a slow turnover rate.
- Average Receivable Collection Period
- The collection of receivables demonstrates the most stability among the three components. A gradual downward trend is observed, moving from 63 days in 2019 and 2020 to a low of 53 days in 2022, ending at 57 days in 2023. This indicates a consistent and slightly improving efficiency in converting credit sales into cash.
- Average Payables Payment Period
- A notable contraction in the payables payment period occurred between 2019 and 2020, dropping from 59 days to 25 days. Since 2020, the period has shown a slight recovery, oscillating between 31 and 38 days, but it has not returned to the 2019 baseline. This reduction in the payment period effectively shortens the time the company holds onto cash, thereby contributing to an increase in the overall cash conversion cycle.
The synthesis of these metrics reveals that the expansion of the cash conversion cycle is predominantly attributable to prolonged inventory holding periods and a reduction in the time allowed for payables settlement. These factors outweigh the marginal gains achieved in receivable collection efficiency.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?